AbbVie Inc. Additional Paid-in Capital 2013-2026 | ABBV
Beta
What is AbbVie Inc.'s current additional paid-in capital?
AbbVie Inc. (ABBV) annual additional paid-in capital for 2025 was $22.50B, a 5.45% increase from 2024. AbbVie Inc. additional paid-in capital for the quarter ending March 31, 2026 was $22.96B.
What was AbbVie Inc.'s additional paid-in capital in 2024?
AbbVie Inc. annual additional paid-in capital for 2024 was $21.33B, a 5.71% increase from 2023.
What was AbbVie Inc.'s additional paid-in capital in 2023?
AbbVie Inc. annual additional paid-in capital for 2023 was $20.18B, a 4.86% increase from 2022.
What is AbbVie Inc.'s 5-year additional paid-in capital CAGR?
AbbVie Inc. additional paid-in capital grew at a compound annual growth rate (CAGR) of 5.29% from FY2020 to FY2025, going from $17.38B to $22.50B over 5 years.
Additional Paid-in Capital History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+5.3%
FY2020
$17.38B
→
FY2025
$22.50B
13141516171819202122232425
5 years selected
Additional Paid-in Capital History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $22.50B | +5.4% | 10-K |
| FY2024 | $21.33B | +5.7% | 10-K |
| FY2023 | $20.18B | +4.9% | 10-K |
| FY2022 | $19.25B | +5.1% | 10-K |
| FY2021 | $18.30B | +5.3% | 10-K |
| FY2020 | $17.38B | +14.4% | 10-K |
| FY2019 | $15.19B | +3.0% | 10-K |
| FY2018 | $14.76B | +3.4% | 10-K |
| FY2017 | $14.27B | +4.3% | 10-K |
| FY2016 | $13.68B | +4.6% | 10-K |
| FY2015 | $13.08B | +211.9% | 10-K |
| FY2014 | $4.19B | +14.2% | 10-K |
| FY2013 | $3.67B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →